JP2004537983A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004537983A5 JP2004537983A5 JP2002583469A JP2002583469A JP2004537983A5 JP 2004537983 A5 JP2004537983 A5 JP 2004537983A5 JP 2002583469 A JP2002583469 A JP 2002583469A JP 2002583469 A JP2002583469 A JP 2002583469A JP 2004537983 A5 JP2004537983 A5 JP 2004537983A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- nucleotide
- seq
- polypeptide
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002773 nucleotide Substances 0.000 claims 42
- 125000003729 nucleotide group Chemical group 0.000 claims 42
- 108020004707 nucleic acids Proteins 0.000 claims 32
- 102000039446 nucleic acids Human genes 0.000 claims 32
- 150000007523 nucleic acids Chemical class 0.000 claims 32
- 229920001184 polypeptide Polymers 0.000 claims 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims 23
- 108020004635 Complementary DNA Proteins 0.000 claims 14
- 239000000523 sample Substances 0.000 claims 12
- 102100037131 ATP-binding cassette sub-family C member 12 Human genes 0.000 claims 8
- 101001029062 Homo sapiens ATP-binding cassette sub-family C member 12 Proteins 0.000 claims 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 239000000556 agonist Substances 0.000 claims 6
- 239000005557 antagonist Substances 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 206010008754 Choreoathetosis Diseases 0.000 claims 5
- 150000001450 anions Chemical class 0.000 claims 5
- 230000001314 paroxysmal effect Effects 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 5
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 239000003550 marker Substances 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 101150067199 abcC12 gene Proteins 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 238000009396 hybridization Methods 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 238000009007 Diagnostic Kit Methods 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27275901P | 2001-03-05 | 2001-03-05 | |
| PCT/EP2002/003320 WO2002085943A2 (en) | 2001-03-05 | 2002-03-05 | Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004537983A JP2004537983A (ja) | 2004-12-24 |
| JP2004537983A5 true JP2004537983A5 (enExample) | 2005-12-22 |
Family
ID=23041149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002583469A Pending JP2004537983A (ja) | 2001-03-05 | 2002-03-05 | ヒトａｂｃｃ１２遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1370585A2 (enExample) |
| JP (1) | JP2004537983A (enExample) |
| CA (1) | CA2439693A1 (enExample) |
| WO (1) | WO2002085943A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002072632A2 (en) * | 2001-03-05 | 2002-09-19 | Aventis Pharma S.A. | Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001241446A1 (en) * | 2000-02-03 | 2001-08-14 | Lexicon Genetics Incorporated | Human transporter proteins and polynucleotides encoding the same |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| WO2002072632A2 (en) * | 2001-03-05 | 2002-09-19 | Aventis Pharma S.A. | Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
-
2002
- 2002-03-05 EP EP02712956A patent/EP1370585A2/en not_active Withdrawn
- 2002-03-05 JP JP2002583469A patent/JP2004537983A/ja active Pending
- 2002-03-05 WO PCT/EP2002/003320 patent/WO2002085943A2/en not_active Ceased
- 2002-03-05 CA CA002439693A patent/CA2439693A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2456889T3 (en) | Markers of endometrial cancer | |
| US6020135A (en) | P53-regulated genes | |
| EP3054299B1 (en) | Biomarkers for the early detection of breast cancer | |
| JP4229973B2 (ja) | 男性不妊関連遺伝子Ｓｃｏｔ−ｔ変異と男性不妊の診断方法 | |
| US20140005070A1 (en) | Markers associated with cyclin-dependent kinase inhibitors | |
| AU2008229749A1 (en) | Novel compositions and methods for cancer | |
| EA020795B1 (ru) | Генетические маркеры, ассоциированные с ответом на интерферон-альфа | |
| CA2550900A1 (en) | Methods for detecting markers associated with endometrial disease or phase | |
| JP2008118915A (ja) | 胃癌高発現遺伝子特定による胃癌診断および創薬への利用 | |
| CA2362527A1 (en) | A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer | |
| CA2418422A1 (en) | Novel kallikrein gene | |
| CN107075584A (zh) | Bcr‑abl抑制剂抗性相关突变的检测方法及使用该检测方法用于预测bcr‑abl抑制剂抗性的数据获得方法 | |
| JP2004531241A5 (enExample) | ||
| US6682888B1 (en) | Genes expressed in alzheimer's disease | |
| JP2004537983A5 (enExample) | ||
| KR20170124683A (ko) | 담도암 진단용 신규 바이오마커로서의 융합 유전자 및 융합 단백질 | |
| JP7150018B2 (ja) | 新規なｃｉｐ２ａバリアント及びその使用 | |
| JP2005504830A5 (enExample) | ||
| JP2005253434A (ja) | ２型糖尿病の診断方法 | |
| CA2418848A1 (en) | Cng2b: a novel human cyclic nucleotide-gated ion channel | |
| KR101093508B1 (ko) | 대장암 진단용 조성물 및 그 용도 | |
| KR102279183B1 (ko) | 췌장염 고위험군 진단용 바이오마커 | |
| JP2002345467A (ja) | Ｃ型肝炎ウイルスの型分類用プローブ及びそれを用いたｃ型肝炎ウイルスの型分類方法並びにそれを用いたインターフェロン投与の治療効果を予測する方法。 | |
| KR100908125B1 (ko) | 심근 경색에 관련된 유전자 다형성 및 그의 용도 | |
| KR101138866B1 (ko) | 심근 경색에 관련된 유전자 다형성 및 그의 용도 |